If anyone has any questions go ahead...
I am long and very bullish on Resverlogix but I do my best to refrain from brainless pumping, there are risks here and they are very real. Notwithstanding recent analyst coverage and the 12 month target price of $8.55
The two biggest risks in my opinion are
1) that the science could ultimately fail
2) that the company won't be able to raise the $$$ needed to take them to the finish line
On the reward side if Apabetalone succeeds in treating all the indications that have shown promise, Diabetes, Chronic Kidney Diseases, Fabry's, Alzheimers, Thromboses, Muscular Dystrophy and a number of others...